by Scott Larrivee | Jun 17, 2025 | News
Agreement provides Ratio access to Nusano-produced radioisotopes for oncology diagnostics and therapeutics Accelerates Ratio’s clinical pipeline with copper-64 for PET imaging and lutetium-177 and actinium-225 for targeted therapy Bolsters both companies’...
by Scott Larrivee | Apr 17, 2025 | News
The following is a copy of a press release issued by Clarity Pharmaceuticals on April 17, 2025 in Australia. Minor edits have been made in this copy to account for English spelling preferences in the United States. Highlights Clarity has signed a commercial-scale...
by Scott Larrivee | Feb 5, 2025 | Podcast
On this episode, Talk Radioisotopes hosts Scott Larrivee and Sarah Scouten sit down with Shaemus Gleason, Executive Vice President at Clarity Pharmaceuticals. The discussion highlights Shaemus’s journey through the radiopharmaceutical industry, Clarity’s...
